top of page

Mundipharma announces EU regulatory submission for Nyxoid

Mundipharma have submitted a marketing authorisation application for Nyxoid (intranasal naloxone 1.8 mg in 0.1 ml) to the European Medicines Agency (EMA), seeking approval for the emergency reversal of opioid overdose.




Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page